Klaus Dugi MD Overview

  • Primary Position
  • Chief Executive...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 3

  • Med. Deal Size

Klaus Dugi MD General Information

Biography

Dr. Klaus Dugi serves as Chief Executive Officer and Board Member at Vandria. He serves as Chief Medical Advisor & Venture Partner at ND Capital. He also serves as Board Member at Notify Therapeutics. He serves as Executive Vice President and Chief Medical Officer at Ferring International Center. He also serves as Board Member at AOBiome Therapeutics. Professor Klaus Dugi joined Ferring in October 2017. He is responsible for Global Medical Affairs, Quality Assurance, and Pharmacovigilance. Prior to joining Ferring, he held various leadership roles at Boehringer Ingelheim, including Vice President of Global Medical Affairs, Chief Medical Officer, and, most recently, Managing Director UK & Ireland. A Professor of Medicine, with a specialty in Internal Medicine, He continues to teach medicine at Heidelberg University, Germany. He also spent four years carrying out research at the US National Institutes of Health (NIH) and has published more than 70 manuscripts in peer-reviewed journals including The Lancet and Diabetes.

Contact Information

Primary Position
Chief Executive Officer & Board Member, Vandria
Gender
Male
Total Investments
Email
kl
Address
  • EPFL Innovation Park
  • Bâtiment F
  • 1015 Lausanne
  • Switzerland

Klaus Dugi MD Positions (1)

Firm name Firm type Title Location Industry Since
Vandria Company Chief Executive Officer & Board Member Lausanne, Switzerland Biotechnology

Klaus Dugi MD Board Seats (3)

Company Industry Ownership Status Financing Status Location Since
AOBiome Therapeutics Drug Discovery Privately Held (backing) Venture Capital-Backed Cambridge, MA
Notify Therapeutics Hospitals/Inpatient Services Privately Held (backing) Venture Capital-Backed Copenhagen, Denmark
Vandria Biotechnology Privately Held (backing) Venture Capital-Backed Lausanne, Switzerland

Klaus Dugi MD Lead Partner on Deals (1)

Klaus Dugi MD has been the lead partner on 1 deal. Their latest deal was with Prolevi Bio, a drug discovery company. The deal was made for on 14-Sep-2022.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Prolevi Bio 14-Sep-2022 Seed Round Completed Drug Discovery Lund, Sweden

Klaus Dugi MD Network (24)

Board Members (21)

Name Company Representing Location From
Chun Wu Ph.D AOBiome Therapeutics iCarbonX Cambridge, MA
Gabriela Ecco Ph.D Notify Therapeutics ND Capital Copenhagen, Denmark
AOBiome Therapeutics iCarbonX Cambridge, MA
Vandria ND Capital Lausanne, Switzerland
AOBiome Therapeutics Self Cambridge, MA

Portfolio Executives (3)

Name Company Role Deal date Location
Sahil Gupta Ph.D Prolevi Bio Co-Founder & Chief Executive Officer 14-Sep-2022 Lund, Sweden
Lars Moberg Prolevi Bio Chief Financial Officer 14-Sep-2022 Lund, Sweden
Prolevi Bio Co-Founder & Head of Formulation 14-Sep-2022 Lund, Sweden

Klaus Dugi MD Advisory Roles (1)

Firm name Firm type Title Location Industry Since
ND Capital Investor Chief Medical Advisor & Venture Partner Woodside, CA Venture Capital

Klaus Dugi MD FAQs

  • Who is Klaus Dugi MD?

    Dr. Klaus Dugi serves as Chief Executive Officer and Board Member at Vandria.

  • How much does Klaus Dugi MD typically invest?

    Klaus Dugi MD's median deal size is .

  • What is Klaus Dugi MD’s main position?

    Klaus Dugi MD’s primary position is Chief Executive Officer & Board Member.

  • How many active board seats does Klaus Dugi MD hold?

    Klaus Dugi MD holds 3 board seats including AOBiome Therapeutics, Notify Therapeutics, and Vandria.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »